Multicenter Evaluation of an Investigational Prostate Cancer Methylation Assay

Journal of Urology

Volumn 182, Issue 3, 2009, Pages 1186-1193

  Baden, Jonathan ^a   Green, George ^a   Painter, Jennifer ^a   Curtin, Katy ^a   Markiewicz, Jadwiga ^a   Jones, Jennifer ^a   Astacio, Tara ^a   Canning, Susan ^a   Quijano, Jedidiah ^a   Guinto, Wilson ^a   Leibovich, Bradley C ^b   Nelson, Joel B ^c   Vargo, Janet ^a   Wang, Yixin ^a   Wuxiong, Cao ^a  

^a Veridex LLC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

biological; methylation; prostate; prostate specific antigen; prostatic neoplasms; tumor markers

Indexed keywords

APC; GLUTATHIONE TRANSFERASE P1; PROSTATE SPECIFIC ANTIGEN; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALGORITHM; ARTICLE; CANCER CELL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS;

ADULT; AGED; BIOLOGICAL ASSAY; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; METHYLATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS;

EID: 68149170832     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.05.003     Document Type: Article

References (16)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71
2. Hodge K.K., McNeal J.E., and Stamey T.A. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 142 (1989) 66
3. Mian B.M., Naya Y., Okihara K., et al. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 60 (2002) 836
4. Catalona W.J., Smith D.S., and Ornstein D.K. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 277 (1997) 1452
5. Collin S.M., Martin R.M., Metcalfe C., et al. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 9 (2008) 407
6. Vener T., Derecho C., Baden J., et al. Development of a multiplexed urine assay for prostate cancer diagnosis. Clin Chem 54 (2008) 874
7. Rouprêt M., Hupertan V., Yates D.R., et al. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Clin Cancer Res 13 (2007) 1720
8. Woodson K., O'Reilly K.J., Hanson J.C., et al. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer. J Urol 179 (2008) 508
9. Hoque M.O., Topaloglu O., Begum S., et al. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J Clin Oncol 23 (2005) 6569
10. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98 (2006) 529
11. Damber J.E., and Aus G. Prostate cancer. Lancet 371 (2008) 1710
12. Sokoll L.J., Ellis W., Lange P., et al. A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy. Clin Chim Acta 389 (2008) 1
13. Marks L.S., Fradet Y., Deras I.L., et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 69 (2007) 532
14. Benecchi L., Pieri A.M., Destro Pastizzaro C., et al. Optimal measure of PSA kinetics to identify prostate cancer. Urology 71 (2008) 390
15. Deras I.L., Aubin S.M.J., Blase A., et al. PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 179 (2008) 1587
16. Cronin A.M., and Vickers A.J. Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study. BMC Med Res Meth 8 (2008) 75